Your Feed

Filter by
See content from
Back to the latest
Thumbnail for Undetectable Circulating Tumor Cells in Myeloma Patients | Juan-José Garcés, PhD | ASH 2023
Playlist: ASH 2023

Undetectable Circulating Tumor Cells in Myeloma Patients | Juan-José Garcés, PhD | ASH 2023

Video details & playlist
Thumbnail for Assessing Lenalidomide with Patients Progressing on JAK Inhibitors | James Berenson, MD | ASH 2023
Playlist: ASH 2023

Assessing Lenalidomide with Patients Progressing on JAK Inhibitors | James Berenson, MD | ASH 2023

Video details & playlist
Thumbnail for Applying the EHA/EBMT Grading System for Icaht Following CAR-T Therapy | Kai Rejeski, MD | ASH 2023
Playlist: ASH 2023

Applying the EHA/EBMT Grading System for Icaht Following CAR-T Therapy | Kai Rejeski, MD | ASH 2023

Video details & playlist
Thumbnail for Results from the Optimum/Muknine Trial | Martin Kaiser, MD, FRCP, FRCPath | ASH 2023
Playlist: ASH 2023

Results from the Optimum/Muknine Trial | Martin Kaiser, MD, FRCP, FRCPath | ASH 2023

Video details & playlist
Thumbnail for Effects of Dose Reductions of Lenalidomide in Myeloma Patients | Jens Hillengass, MD, PhD | ASH 2023
Playlist: ASH 2023

Effects of Dose Reductions of Lenalidomide in Myeloma Patients | Jens Hillengass, MD, PhD | ASH 2023

Video details & playlist
Avatar
silverFlamingo
Multiple Myeloma Discussion • December 22, 2023
Sharing My CAR-T Recovery & Light Chain Question
AI-generated title
I had the Car-T transplant in February 2023. It was the last option that I had !! Glad I went through this. It has done pretty good for me. It has taken me some time to get my strength back up but still working hard at it. I also have had some issues with my immune system being really low. I am currently taking IVIG therapy (octogam) to help try to get my immune system to go up. Have had some problems with white counts, platelets, and ANC running low. I also noticed on my last labs in early December, that my kappa light chain numbers rose slightly. Is this something that I need to be concerned with or is it just part of the Car-T process ?? I really appreciate getting to read about others going through the Car-T and am Praying🙏🙏 for everyone here and also with other cancers !! We will win this battle !! Do not give up !! New medicines are being made every day !!
Thumbnail for Talquetamab + Pomalidomide in Myeloma: MonumenTAL-2 Safety & Efficacy | Jeffrey Matous, MD |ASH 2023
Playlist: ASH 2023

Talquetamab + Pomalidomide in Myeloma: MonumenTAL-2 Safety & Efficacy | Jeffrey Matous, MD |ASH 2023

Video details & playlist
Avatar
Dave Braucht
Multiple Myeloma Discussion • December 21, 2023
Join Our Webinar on Cardiac Amyloidosis
AI-generated title
The Amyloidosis Support Groups is having a Zoom webinar next month. This Webinar is for all Types of Amyloidosis with Cardiac Involvement Please Join Us Saturday January 20th Noon Eastern 9 Pacific Time. Our Guest Cardiologists: Dr. Melissa Lyle, Mayo Clinic Jacksonville; Dr. Barry Trachtenberg, Houston Methodist; and Dr. Justin Grodin, UT Southwestern Have a question for the doctors? Email it IN ADVANCE to info@amyloidosissupport.org Registery for the webinar by clicking below. Note: Click the Zoom picture to register as the link the bottom is for joining in the 20th. https://amyloidosissupport.zoom.us/webinar/register/WN_8QVEA0rlSJq8_m2T4He_nw#/registration
Video Conferencing, Web Conferencing, Webinars, Screen Sharing

Video Conferencing, Web Conferencing, Webinars, Screen Sharing

Zoom is the leader in modern enterprise video communications, with an easy, reliable cloud platform for video and audio conferencing, chat, and webinars across mobile, desktop, and room systems. Zoom Rooms is the original software-based conference room solution used around the world in board, conference, huddle, and training rooms, as well as executive offices and classrooms. Founded in 2011, Zoom helps businesses and organizations bring their teams together in a frictionless environment to get more done. Zoom is a publicly traded company headquartered in San Jose, CA.

https://amyloidosissupport.zoom.us/webinar/register/WN_8QVEA0rlSJq8_m2T4He_nw#/registration
Thumbnail for Inflammatory Marker Levels, Age, Race and Prior Treatment Burden | Santiago Thibaud, MD | ASH 2023
Playlist: ASH 2023

Inflammatory Marker Levels, Age, Race and Prior Treatment Burden | Santiago Thibaud, MD | ASH 2023

Video details & playlist
Thumbnail for Safety and Efficacy of Cilta Cel: CARTITUDE-2 Study | Jens Hillengass, MD, PhD | ASH 2023
Playlist: ASH 2023

Safety and Efficacy of Cilta Cel: CARTITUDE-2 Study | Jens Hillengass, MD, PhD | ASH 2023

Video details & playlist
Thumbnail for Importance of Caregivers for Patients with Multiple Myeloma | Hamza Hashmi | ASH 2023
Playlist: ASH 2023

Importance of Caregivers for Patients with Multiple Myeloma | Hamza Hashmi | ASH 2023

Video details & playlist
Thumbnail for Serum Biomarkers and Progression Risk in Smoldering Myeloma | Theresia Akhalghi, MD | ASH 2023
Playlist: ASH 2023

Serum Biomarkers and Progression Risk in Smoldering Myeloma | Theresia Akhalghi, MD | ASH 2023

Video details & playlist
Thumbnail for Pathogenic Germline Variants in Cancer Predisposition Genes | Santiago Thibaud, MD | ASH 2023
Playlist: ASH 2023

Pathogenic Germline Variants in Cancer Predisposition Genes | Santiago Thibaud, MD | ASH 2023

Video details & playlist